Lupin partners with LABORATORIOS ERN to launch Luforbec in Spain
Collaboration combines Lupin’s inhaler manufacturing capabilities with ERN’s strong commercial presence to expand access to respiratory care
Collaboration combines Lupin’s inhaler manufacturing capabilities with ERN’s strong commercial presence to expand access to respiratory care
New Chesterbrook office strengthens customer engagement, partner collaboration, and regional expansion strategy
The collaboration will foster joint research initiatives, scientific knowledge exchange, and innovation
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
We are building the bridge between complex molecular data and everyday clinical decisions
Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy
Community healthcare initiatives reach a milestone year, with services spanning 90 districts, 22 states, and over 70 lakh cumulative beneficiaries since 2006
The graduating cohort comprised seven batches across five specialized programs
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
The program expected to commence in August 2026 will be offered across multiple specialised areas with an intake of 20-30 students per course
Subscribe To Our Newsletter & Stay Updated